BeStock  
Markets › Compare › PRAX vs KYMR

PRAX vs KYMR

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
PRAX · Praxis Precision Medicines$300.43 ▼ 3.37%
KYMR · Kymera Therapeutics$115.31 ▼ 3.42%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

87120153186219Nov 24, '25May 26, '26Nov 20, '26
  • PRAX +57.4%
  • KYMR +75.8%

Head to head

MetricPRAXKYMR
Price$300.43$115.31
Change today▼ 3.37%▼ 3.42%
Market cap$8.40B$9.84B
Return, 3 months-18.4%-4.7%
Return, year to date+1.9%+48.2%
Return, 1 year+76.9%+74.6%
P/E (TTM)––
P/B6.76.1
P/E percentile vs own 5y3rd3rd
Dividend yield––
Revenue growth (YoY, latest qtr)–-100.0%
Net profit growth (YoY)-27.5%-60.6%
Gross margin––
Operating margin–-396.0%
Net margin–-341.8%
Return on equity-44.8%-27.3%
Analyst target vs. price+142.4%+30.7%
Analyst buy share92%100%
RSI (14)5141
30-day volatility80.1%51.7%
Max drawdown, 1 year-38.1%-27.7%
Trend readLeaning bullishLeaning bearish
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • KYMR is the largest of the group by market value.
  • PRAX has returned the most over the past year.
  • KYMR has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top